Total Funding
39
78
Total FundingGrant raised
Growth Score 39 in past quarter
-3 pts
Heat Score 78 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58837
Phoenix PharmaLabs believes strongly in the value to the worldwide human family of a class of potent analgesics.
Bill Crossman: President & CEO- Lawrence Toll: Founder and Chief Neuropharmacologist
About the Company
Phoenix PharmaLabs believes strongly in the value to the worldwide human family of a class of potent analgesics with the potential to relieve pain and suffering without the problems of addiction, side effects and death.
The Company believes that superior shareholder and investor return can be accomplished while delivering relief to millions of
pain sufferers and opiate addicts.

